Alphavbeta3integrin as a predictor of endometriosis
OA: closed
AI-generated summary
This patent describes diagnostic methods for endometriosis by detecting the alpha v beta 3 integrin subunit in endometrial samples using specific reagents to identify the condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The present invention relates to methods of diagnosing fertility and monitoring endometrial maturation comprising monitoring the appearance of the 3 subunit of integrin in an endometrium sample from a plurality of stages of the menstrual cycle. The invention further discloses methods of assaying for 3 integrin in an endometrium sample comprising contacting the sample with a reagent specific for 3 integrin and detecting 3 integrin in said sample as a diagnostic indicator of endometriosis.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-08-16T09:21:09.727480+00:00